
Page#1
ZOETIS INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
Year Ended December 31,
(MILLIONS OF DOLLARS AND SHARES, EXCEPT PER SHARE DATA) 2019 2018 2017
Revenue $ 6,260 $ 5,825 $ 5,307
Costs and expenses:
Cost of sales(a) 1,992 1,911 1,775
Selling, general and administrative expenses(a) 1,638 1,484 1,334
Research and development expenses(a) 457 432 382
Amortization of intangible assets 155 117 91
Restructuring charges and certain acquisition-related costs 51 68 19
Interest expense, net of capitalized interest 223 206 175
Other (income)/deductions––net (57) (83) 6
Income before provision for taxes on income 1,801 1,690 1,525
Provision for taxes on income 301 266 663
Net income before allocation to noncontrolling interests 1,500 1,424 862
  Less: Net loss attributable to noncontrolling interests — (4) (2)
Net income attributable to Zoetis $ 1,500 $ 1,428 $ 864
Earnings per share attributable to Zoetis Inc. stockholders:
 Basic $ 3.14 $ 2.96 $ 1.76
 Diluted $ 3.11 $ 2.93 $ 1.75
Weighted-average common shares outstanding:
 Basic 478.128 483.063 489.918
 Diluted 481.787 486.898 493.161
Dividends declared per common share $ 0.692 $ 0.542 $ 0.441
(a) Exclusive of amortization of intangible assets, except as disclosed in Note 3. Significant Accounting Policies—Amortization of Intangible Assets, Depreciation and 
Certain Long-Lived Assets. 
63 |
Page#2
ZOETIS INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS 
December 31, December 31,
(MILLIONS OF DOLLARS, EXCEPT PER SHARE DATA) 2019 2018
Assets
Cash and cash equivalents(a) $ 1,934 $ 1,602
Short-term investments — 99
Accounts receivable, less allowance for doubtful accounts of $21 in 2019 and $24 in 2018 1,086 1,036
Inventories 1,410 1,391
Other current assets 318 271
Total current assets 4,748 4,399
Property, plant and equipment, less accumulated depreciation of $1,737 in 2019 and $1,599 in 2018 1,940 1,658
Operating lease right of use assets 189 —
Goodwill 2,592 2,519
Identifiable intangible assets, less accumulated amortization 1,890 2,046
Noncurrent deferred tax assets 88 61
Other noncurrent assets 98 94
Total assets $ 11,545 $ 10,777
Liabilities and Equity
Short-term borrowings $ — $ 9
Current portion of long-term debt 500 —
Accounts payable 301 313
Dividends payable 95 79
Accrued expenses 543 487
Accrued compensation and related items 276 266
Income taxes payable 36 35
Other current liabilities 55 34
Total current liabilities 1,806 1,223
Long-term debt, net of discount and issuance costs 5,947 6,443
Noncurrent deferred tax liabilities 434 474
Operating lease liabilities 164 —
Other taxes payable 257 265
Other noncurrent liabilities 229 187
Total liabilities 8,837 8,592
Commitments and contingencies (Note 18)
Stockholders' equity:
Common stock, $0.01 par value: 6,000,000,000 authorized, 501,891,243 and 501,891,243 shares issued;  
475,528,210 and 479,562,326 shares outstanding at December 31, 2019 and 2018, respectively 5 5
Treasury stock, at cost, 26,363,033 and 22,328,917 shares of common stock at December 31, 2019 and 2018,
respectively (2,042) (1,487)
Additional paid-in capital 1,044 1,026
Retained earnings 4,427 3,270
Accumulated other comprehensive loss (726) (629)
Total equity 2,708 2,185
Total liabilities and equity $ 11,545 $ 10,777
(a) As of December 31, 2019 and December 31, 2018, includes $2 million and $5 million, respectively, of restricted cash.
65 |
Page#3
  ZOETIS INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Year Ended December 31,
(MILLIONS OF DOLLARS) 2019 2018 2017
Operating Activities
Net income before allocation to noncontrolling interests $ 1,500 $ 1,424 $ 862
Adjustments to reconcile net income before noncontrolling interests to net cash provided by operating activities:
Depreciation and amortization expense 412 308 242
Share-based compensation expense 67 53 44
Asset write-offs and asset impairments 7 4 3
Net (gain)/loss on sales of assets (20) (42) 11
Provision for losses on inventory 68 54 54
Deferred taxes(a) (79) (112) 127
Employee benefit plan contribution from Pfizer Inc. 3 3 3
Other non-cash adjustments (12) (14) 10
Other changes in assets and liabilities, net of acquisitions and divestitures
Accounts receivable (69) (67) (50)
Inventories (104) 61 19
Other assets (51) (42) (16)
Accounts payable (10) 37 (10)
Other liabilities 91 56 (38)
Other tax accounts, net (8) 67 85
Net cash provided by operating activities 1,795 1,790 1,346
Investing Activities
Capital expenditures (460) (338) (224)
Acquisition of Abaxis, net of cash acquired — (1,884) —
Other acquisitions (195) (114) (82)
Proceeds from maturities and redemptions of investments 101 28 —
Net proceeds on swaps designated as net investment hedges 37 — —
Net proceeds from sales of assets 21 56 37
Other investing activities (8) (7) (1)
Net cash used in investing activities (504) (2,259) (270)
Financing Activities
(Decrease)/increase in short-term borrowings, net (9) 8 —
Principal payments on long-term debt — — (750)
Proceeds from issuance of long-term debt—senior notes, net of discount and fees — 1,485 1,231
Payment of contingent consideration related to previously acquired assets (9) (12) (7)
Share-based compensation-related proceeds, net of taxes paid on withholding shares and excess tax benefits 7 19 24
Purchases of treasury stock (626) (698) (500)
Cash dividends paid (314) (243) (206)
Acquisition of a noncontrolling interest — (26) (43)
Net cash (used in)/provided by financing activities (951) 533 (251)
Effect of exchange-rate changes on cash and cash equivalents (8) (26) 12
Net increase in cash and cash equivalents 332 38 837
Cash and cash equivalents at beginning of period 1,602 1,564 727
Cash and cash equivalents at end of period $ 1,934 $ 1,602 $ 1,564
Supplemental cash flow information
Cash paid during the period for:
 Income taxes $ 418 $ 336 $ 455
 Interest, net of capitalized interest 247 190 167
Non-cash transactions:
 Capital expenditures $ 7 $ 7 $ 5
 Contingent purchase price consideration 23 — 29
 Dividends declared, not paid 95 79 61
(a) For 2018, reflects the reclassification of the one-time deemed repatriation tax from Noncurrent deferred tax liabilities to Income taxes payable and Other taxes payable to properly reflect the 
liability, which became a fixed obligation in 2018, payable over eight years.
67 |